Cowen Financial Products Amends Apyx Medical Corp. Stake

TL;DR

**Cowen Financial Products updated its stake in Apyx Medical Corp. as of Dec 29, 2023.**

AI Summary

Cowen Financial Products LLC, a New York-based financial entity, has filed an amended Schedule 13G/A for Apyx Medical Corp. This filing, dated February 2, 2024, indicates a change in their beneficial ownership of Apyx Medical Corp.'s common stock as of December 29, 2023. While the specific change in share count isn't detailed in the provided text, the amendment suggests an update to their previously reported holdings. This matters to investors because significant changes in institutional ownership can signal shifts in confidence or strategy regarding the stock.

Why It Matters

Changes in institutional ownership can influence stock price and investor sentiment, as large investors often have significant research capabilities.

Risk Assessment

Risk Level: low — This filing is a routine update on institutional ownership and does not inherently signal a high-risk event.

Analyst Insight

Investors should monitor subsequent filings from Cowen Financial Products LLC to understand the specific change in their beneficial ownership of Apyx Medical Corp. and assess if it aligns with their own investment thesis.

Key Players & Entities

• Cowen Financial Products LLC (company) — the reporting person filing the SC 13G/A
• Apyx Medical Corp. (company) — the subject company whose securities are being reported
• December 29, 2023 (date) — the date of the event requiring the filing
• February 2, 2024 (date) — the filing date of the SC 13G/A

FAQ

Filing Documents

• apyxa3_20224.htm (SC 13G/A) — 25KB
• 0001085146-24-000637.txt ( ) — 27KB

(a)

ITEM 1(a). NAME OF ISSUER: Apyx Medical Corp.

(b)

ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 5115 Ulmerton Rd Clearwater, Fla 33760

(a)

ITEM 2(a). NAME OF PERSON FILING: Cowen Financial Products LLC

(b)

ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 599 Lexington Ave New York, NY 10022

(c)

ITEM 2(c). CITIZENSHIP: USA

(d)

ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock

(e)

ITEM 2(e). CUSIP NUMBER: 03837c106 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. (a) Amount beneficially owned: 0 (b) Percent of class: 0 (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: Cowen Financial Products LLC : 0 (ii) shared power to vote or to direct the vote: Cowen Financial Products LLC : (iii) sole power to dispose or direct the disposition of: Cowen Financial Products LLC : 0 (iv) shared power to dispose or to direct the disposition of: Cowen Financial Products LLC : ITEM 5. If this statement is being filed to report the fact that as of the date hereof the reporting pers

View Full Filing

View this SC 13G/A filing on SEC EDGAR